-
‘Irresistins’: have scientists discovered a drug that defeats superbugs?
Speed Read Breakthrough dubbed the ‘holy grail’ of antibiotics research
Speed Read -
Instant Opinion: ‘women the stronger sex’ in coronavirus crisis
In Depth Your guide to the best columns and commentary on Monday 18 May
In Depth -
Instant Opinion: EU ‘will be destroyed by handling of coronavirus crisis’
In Depth Your guide to the best columns and commentary on Thursday 2 April
In Depth -
Policing a pandemic: coronavirus restrictions ‘may fuel gang wars’
In Depth New report by former counterterrorism commander analyses outbreak’s potential impact on crime and law
In Depth -
Why is Canada’s black-market cannabis market booming?
In Depth Many users still buy from unlicensed dealers despite legalisation of the drug
In Depth -
Drugs as easy to buy online as pizza, says government report
In Depth Independent review warns of ‘abundant supply’ of illegal narcotics coming into UK
In Depth -
Three reasons why the Tories might legalise cannabis
In Depth Potential for raising tax revenue may be among the most compelling attractions
In Depth -
Mexico murder rate hits all-time high
In Depth Nearly 35,000 people were killed in 2019 despite government pledge to curb cartel violence
In Depth -
Instant Opinion: Capitalism ‘still best hope for roaring Twenties’
In Depth Your guide to the best columns and commentary on Thursday 2 January
In Depth -
How magic mushroom medicine could treat depression
Speed Read Active ingredient psilocybin is found to have no harmful effects in its first clinical trial
Speed Read -
Nitrous oxide: why Amazon and eBay are under pressure to ban sales
In Depth Online retailers selling drug paraphernalia
In Depth -
Medical cannabis trial to target 20,000 UK patients
In Depth Project Twenty21 will test seven medical conditions including chronic pain
In Depth -
What are county lines?
In Depth More than 700 arrests made in nationwide crackdown
In Depth -
Fact Check: how bad is America’s opioid crisis?
In Depth Drugmaker Johnson & Johnson hit with $572m fine for its part in opioid crisis
In Depth
